Polen Capital Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,738
Closed -$102K 284
2025
Q4
$102K Buy
+21,738
New +$98.5K ﹤0.01% 234

Other funds holding SOPH

Polen Capital Management's SOPH Position: Q1 2026 in Review

Polen Capital Management sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 21,738 shares — an estimated $102K sold.

Polen Capital Management first reported a position in SOPH in Q4 2025 and held it in 1 quarter. The position peaked at $102K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Polen Capital Management reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • Polen Capital Management sold 21,738 SOPHiA GENETICS shares in Q1 2026, an estimated $102K.
  • Polen Capital Management first reported a position in SOPHiA GENETICS in Q4 2025 and held it in 1 quarter.
  • Polen Capital Management's SOPHiA GENETICS position peaked at $102K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Polen Capital Management's 13F filing for Q1 2026, filed 14 May 2026.